View in EDS HTML Full Text PDF Full Text

Subcutaneous Trastuzumab: An Observational Study of Safety and Tolerability in Patients With Early HER2‐Positive Breast Cancer.

Saved in:
Bibliographic Details
Title: Subcutaneous Trastuzumab: An Observational Study of Safety and Tolerability in Patients With Early HER2‐Positive Breast Cancer.
Authors: Otoya, Iris1 (AUTHOR) iris.otoyaf@gmail.com, Valdiviezo, Natalia1 (AUTHOR), Morante, Zaida1 (AUTHOR), Calle, Cindy1 (AUTHOR), Ferreyra, Yomali2 (AUTHOR), Huarcaya-Chombo, Norma3 (AUTHOR), Polo-Mendoza, Gabriela2 (AUTHOR), Castañeda, Carlos1 (AUTHOR), Vidaurre, Tatiana1 (AUTHOR), Neciosup, Silvia P.1 (AUTHOR), Calderón, Mónica J.1,4 (AUTHOR), Gomez, Henry L.1,4,5 (AUTHOR), Sahgal, Pranshu (AUTHOR) pranshu_sahgal@dfci.harvard.edu
Source: International Journal of Breast Cancer. 6/22/2024, Vol. 2024, p1-12. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20903170
DOI:10.1155/2024/9551710